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Carlo Palmieri1,2,3  · Rob C. Stein4 · Xinxue Liu3 · Emma Hudson3 · Hanna Nicholas3 ·  
Hironobu Sasano5 · Fouzia Guestini5 · Chris Holcombe6 · Sophie Barrett7 ·  
Laura Kenny3 · Sadie Reed3 · Adrian Lim8 · Larry Hayward9 · Sacha Howell10 ·  
R. Charles Coombes3 · On behalf of the IRIStrial participants
‘The study was coordinated by the Imperial Clinical Tri-
als Unit—Cancer, Imperial College London and Sponsored 
by Imperial College London. The Imperial Clinical Trials 
Unit receives funding from the National Institute for Health 
(NIHR) Biomedical Research Centre based at Imperial Col-
lege Healthcare NHS Trust and Imperial College London. 
The views expressed are those of the author(s) and not nec-
essarily those of the NHS, the NIHR or the Department of 
Health. This study was supported by Imperial Experimental 
Cancer Medicine Centre and Cancer Research UK Imperial 
Centre’.
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In the original publication of the article, a part of acknowl-
edgement section was missed out. The omitted acknowledge-
ment is given below:
The online version of the original article can be found under 
doi:10.1007/s10549-017-4328-z.
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